Clinical Trial Update: External Beam Therapy With Theranostic Radioligand Therapy for Oligometastatic Prostate Cancer (ProstACT TARGET) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating external beam therapy in combination with theranostic radioligand therapy for oligometastatic prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED